ATM program
Issued 2021
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ZNTL$1.82-1.62%
Zentalis Pharmaceuticals, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$178.6M
Float & O/S:
Inst Own:
DilutionScan read 30 of Zentalis Pharmaceuticals, Inc.'s SEC filings and found 1 ATM program, 2 shelf registrations and 2 completed offerings on file for ZNTL. The latest dilution event on file is an offering on Aug 17, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
Raise routes on file: active ATM + effective shelf · latest dilution event 78 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Aug 17, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Active
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3ASR shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
ATM block sale
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ZNTL trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
